Propofol for gastrointestinal endoscopy

Toshihiro Nishizawa, Hidekazu Suzuki

研究成果: Review article査読

21 被引用数 (Scopus)

抄録

Most gastrointestinal endoscopic procedures are now performed with sedation. Moderate sedation using benzodiazepines and opioids continues to be widely used, but propofol sedation is becoming more popular because its unique pharmacokinetic properties make endoscopy almost painless, with a very predictable and rapid recovery process. There is controversy as to whether propofol should be administered only by anesthesia professionals. According to published values, endoscopist-directed propofol has a lower mortality rate than endoscopist-delivered benzodiazepines and opioids, and a comparable rate to general anesthesia by anesthesiologists. Rapid recovery has a major impact on patient satisfaction, post-procedure education and the general flow of the endoscopy unit. According to estimates, the absolute economic benefit of endoscopist-directed propofol implementation in a screening setting is probably substantial, with 10-year savings of $3.2 billion in the USA. Guidelines concerning the use of propofol emphasize the need for adequate training and certification in sedation by non-anesthetists.

本文言語English
ページ(範囲)801-805
ページ数5
ジャーナルUnited European Gastroenterology Journal
6
6
DOI
出版ステータスPublished - 2018 7月 1

ASJC Scopus subject areas

  • 腫瘍学
  • 消化器病学

フィンガープリント

「Propofol for gastrointestinal endoscopy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル